Literature DB >> 8627082

The public health impact of Lyme disease in Maryland.

B S Coyle1, G T Strickland, Y Y Liang, C Peña, R McCarter, E Israel.   

Abstract

The purpose of this study was to estimate the health burden imposed by Lyme disease (LD) in Maryland during 1992 and 1993. A cross-sectional 1-in-15 survey of physicians (total, 1200) in Maryland was conducted to estimate the incidence of diagnosed LD, presumptive cases of LD, patients with tick bites, and diagnostic tests ordered for LD. Results show that LD is underreported by 10- to 12-fold in Maryland, that 80% of cases are managed by primary care physicians, and that there is discordance between the actual clinical treatment of patients and the recommended approach. In addition, the much greater numbers of patients treated for presumptive LD, seen and given prophylaxis for tick bites, and having diagnostic tests indicate that real and perceived LD is a far greater public health problem and uses more medical resources than official surveillance data suggest.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627082     DOI: 10.1093/infdis/173.5.1260

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

Review 1.  Occupational risk of Lyme disease: an epidemiological review.

Authors:  J D Piacentino; B S Schwartz
Journal:  Occup Environ Med       Date:  2002-02       Impact factor: 4.402

2.  Assessing diagnostic coding practices among a sample of healthcare facilities in Lyme disease endemic areas: Maryland and New York - A Brief Report.

Authors:  N Thomas; H J Rutz; S A Hook; A F Hinckley; G Lukacik; B P Backenson; K A Feldman; J L White
Journal:  Zoonoses Public Health       Date:  2017-10-30       Impact factor: 2.702

3.  Using administrative medical claims data to supplement state disease registry systems for reporting zoonotic infections.

Authors:  Stephen G Jones; Steven Coulter; William Conner
Journal:  J Am Med Inform Assoc       Date:  2012-07-18       Impact factor: 4.497

4.  Adjuvanted Lyme disease vaccine: a review of its use in the management of Lyme disease.

Authors:  S V Onrust; K L Goa
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

5.  The cost effectiveness of vaccinating against Lyme disease.

Authors:  M I Meltzer; D T Dennis; K A Orloski
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

6.  Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection.

Authors:  John N Aucott; Ari Seifter; Alison W Rebman
Journal:  BMC Infect Dis       Date:  2012-08-01       Impact factor: 3.090

7.  Effect of surveillance method on reported characteristics of Lyme disease, Connecticut, 1996-2007.

Authors:  Starr-Hope Ertel; Randall S Nelson; Matthew L Cartter
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

8.  Misdiagnosis of early Lyme disease as the summer flu.

Authors:  John N Aucott; Ari Seifter
Journal:  Orthop Rev (Pavia)       Date:  2011-06-29

9.  Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010.

Authors:  Christina A Nelson; Shubhayu Saha; Kiersten J Kugeler; Mark J Delorey; Manjunath B Shankar; Alison F Hinckley; Paul S Mead
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

10.  Diagnostic challenges of early Lyme disease: lessons from a community case series.

Authors:  John Aucott; Candis Morrison; Beatriz Munoz; Peter C Rowe; Alison Schwarzwalder; Sheila K West
Journal:  BMC Infect Dis       Date:  2009-06-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.